Health:Further 112 - AI Replacing Jobs, JP Morgan's Bold Move, and Healthcare's Biggest Shakeups Yet!
Economic implications of the jobs report and inflation trends, how bond yields are shaping global markets, and the impact of AI on mid-level job markets. They analyze JP Morgan's office return mandate, Meta's corporate shifts, and major VC and healthcare developments like Eli Lilly's new venture fund with Andreessen Horowitz. The episode concludes with insights into challenges in Medicare Advantage, value-based care, and the growing role of AI in medicine.
3:18 - Hiring Blew Past Expectations With 256,000 Jobs Added in December
5:08 - Inflation Rises Again, Hitting 2.9% in December
6:37 - Why Bond Yields Are Surging Around the World
8:58 - JPMorgan Chase Disables Employee Comments After Return-to-Office Backlash
11:57 - Balance of Power Shifts Back Toward Bosses
17:50 - Meta to Cut Roughly 5% of Staff, Targeting Lowest Performers
21:38 - Innovaccer clinches $275M series F funding to build out AI, cloud capabilities
22:43 - IntusCare Increases Total Funding to Over $27M through Strategic Follow-On Funding IntusCare website
24:39 - Spurred by AI’s possibilities, Eli Lilly and Andreessen Horowitz partner on $500M venture fund Stat
26:09 - VC firms back exchange-based employee health benefits
28:12 - Trump Says World Is Free-Riding on U.S. Health Spending. He Has a Point
34:39 - SCOTUS agrees to hear challenge to Obamacare’s preventive care coverage
35:56 - House GOP puts Medicaid, ACA, climate measures on chopping block
36:51 - FDA Bans Artificial Dye Red 3 From Food
40:59 - UnitedHealth’s Earnings Point to High Medical Costs in 2025. Health Insurer Stocks Sink. Barrons
44:57 - Docs incensed by Medicare Advantage hike, demand physician payment update
46:50 - Nearly 5,000 Providence nurses, doctors launch Oregon's largest healthcare strike
48:36 - Health systems eye $30 billion revenue target
52:40 - Avel eCare acquires Amwell Psychiatric Care, expands to 46 states
53:54 - Prospect Medical Holdings files for Chapter 11 amid criticisms of prior PE ownership
57:30 - Johnson & Johnson to Acquire Intra-Cellular in $15 Billion Deal
58:29 - Eli Lilly to Buy Scorpion Therapeutics Drug Program in $2.5 Billion Deal
58:47 - Kids Turn to a Mental-Health Chatbot to Share Their Anxieties